jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Pharmacognosy ReviewsNOW IN
Review

Hepcidin - A novel biomarker with changing trends

Arunava Kali1★, Marie Victor Pravin Charles1, Rathan Shetty Kolkebail Seetharam2★ Corresponding author

  1. 1Departments of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pillayarkuppam, Puducherry, INDIA.
  2. 2Otorhinolaryngology, Mahatma Gandhi Medical College and Research Institute, Pillayarkuppam, Puducherry, INDIA.

CORRESPONDENCE

Arunava Kali

Departments of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pillayarkuppam, Puducherry, INDIA.

ak.arunava@gmail.com

Received: 09-05-2014; Revised: 23-05-2014; Accepted: 05-05-2015.

Volume 9, Issue 17 · pp. 35–40 · PUBLISHED · DOI: 10.4103/0973-7847.156333

View on PR original site ↗

ABSTRACT

Hepcidin is a novel peptide hormone of hepatic origin. It has a crucial role in iron metabolism. The causative association of this peptide in anemia and iron overloading states has been well established. Current research has expanded the diagnostic implications of hepcidin in other medical conditions. Increased serum hepcidin has been reported in neoplastic diseases, inflammation, and sepsis. However, the clinical use of hepcidin as a biomarker is limited owing to nonavailability of an appropriate diagnostic test. Assays for serum and urine hepcidin estimation have been developed recently, which are likely to facilitate the use of hepcidin in research as well as in patient care in the near future.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Kali, A., Charles, M. V. P., & Seetharam, R. S. K. (). Hepcidin - A novel biomarker with changing trends. Pharmacognosy Reviews, 9(17), 35–40. https://doi.org/10.4103/0973-7847.156333